FDA Inspection 1256410 — Soulaire Corporation
The FDA completed an inspection of Soulaire Corporation on December 5, 2024 in Santa Monica, CA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Devices.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- December 5, 2024
- Fiscal Year
- 2025
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Santa Monica, CA (United States)